← Open Payments lookup

CHIOMA IROEGBU: Open Payments

NPI 1518678390 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$697 in 24 payments from 5 companies in 2025. Trend: 2023 $31 · 2024 $0 · 2025 $697

Food & beverage: $697
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$456
Neurocrine BioSciences, Inc.7$171
E.R. Squibb & Sons, L.L.C.1$28
Teva Pharmaceuticals USA, Inc.1$23
Alkermes, Inc.1$19

Products named: CAPLYTA, INGREZZA, COBENFY, AUSTEDO XR, ARISTADA.

Industry payments across MD — which companies pay providers there.